Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Step and think: new combo exercise boosts body and brain in seniors with diabetes

NCT ID NCT07330700

Symptom relief Sponsor: Chonticha Kaewjoho Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a marching exercise combined with mental tasks (like counting backwards) can improve physical performance, thinking, and heart health in older adults with type 2 diabetes. Sixty participants were split into two groups: one did the combined exercise and cognitive training, while the other received usual care. Researchers measured balance, strength, walking ability, and heart rate variability before and after the program to see if the combo approach works better than standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
marching exercise combined with cognitive training
What this could lead to
If it works, this could offer a simple, safe exercise program to help older adults with type 2 diabetes improve their physical fitness, thinking skills, and heart health.
What could go wrong
This is a small, completed trial with only 60 participants, so results may not apply to everyone. The exercise is low-risk, but benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jul 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male and female. 2. Aged between 60 and 79 years. 3. Medically diagnosed with type 2 diabetes. 4. Peripheral neuropathy with a score of 7 or higher according to the Michigan Neuropathy Screening Instrument (MNSI). 5. Body Mass Index (BMI) within the normal range (between 18.5-24.5 kg/m²). 6. Able to follow instructions and willing to participate in the study. 7. Able to communicate with researchers and provide information independently (researchers will read the questions to the volunteers and allow them to choose their own answers). 8. Able to walk continuously for at least 10 meters without the use of walking aids. Exclusion Criteria: 1. Neurological disease (e.g., stroke, Parkinson's disease, spinal cord injury) that affects mobility, such as balance and gait. 2. Open wounds on the skin that affect weight-bearing while standing or walking. 1) Deformities or abnormalities of the extremities, or disabilities resulting from the loss of limbs that may affect the study. 2\) Inflammation of joints and muscles, or musculoskeletal conditions with a pain score greater than 5 out of 10 on the Visual Analogue Scale (VAS), or any pain that affects the study. 3\) A history of ankle, knee, or hip joint replacement within 6 months prior to participation in the study, or any residual effects from surgery that affect the study. 4\) Hearing and vision impairments that cannot be corrected with hearing aids and glasses, etc. 5\) Other complications that may affect the study, such as dizziness, angina pain, uncontrolled high blood pressure, acute illness, or injury, etc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autonomic nervous system imbalance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autonomic nervous system imbalance TYPE2 diabetes mellitus

Contacts and locations

Locations

  • Chonticha Kaewjoho

    Phayao, 56000, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.